Wednesday, Feb 5, 2025 · SEC filings

What the smart money revealed on Feb 5

Real insider buys23insiders · $6.1M
Real insider sales109insiders · $149M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

764 insider filings came in. We hid 120 planned (10b5-1) sellers and 487 people whose filings were routine, like grants and tax withholding.

trending_up

Atlas Energy Solutions (AESI) Executive Chairman Ben Brigham bought $5M

217,391 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Feb 3
$5M
trending_up

MBX Biosciences (MBX) President and CEO P. Kent Hawryluk bought $534K

50,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 3 beat Traded Feb 4
$534K
trending_up

LendingClub (HAPN) Director Michael Zeisser bought $258K

20,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Feb 3
$258K
trending_up

Mid Penn Bancorp (MPB) Director Matthew De Soto bought $105K

3,610 shares on the open market. Not a grant or an option exercise. Their past buys: 8 of 10 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 8 of 10 beat Traded Feb 4
$105K
trending_down

Celestica (CLS) CEO Robert Mionis sold $54M

Not marked as a planned 10b5-1 sale. Sold 45% of the shares they held directly. Still holds 531,417 shares.

Real sale Form 4 Sold 45% of stake Traded Feb 3
$54M
trending_down

Celestica (CLS) President Jason Phillips sold $11.7M

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Feb 3
$11.7M
trending_down

Celestica (CLS) CFO Mandeep Chawla sold $11.1M

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Feb 3
$11.1M
Show 19 more real buys
BHRB Burke & Herbert Financial Services · Director Gary Hinkle · Traded Feb 5
$71.1K
CAT Caterpillar · Director Gerald Johnson · Traded Feb 4
$36.6K
CBNA Chain Bridge Bancorp · Director Michael Conover · Traded Feb 3–4
$24.7K
PNC PNC Financial Services Group · Director Douglas Dachille · Traded Feb 3
$19.8K
MBWM Mercantile Bank · Director Nelson Sanchez · Traded Feb 3–4
$17.9K
ISBA Isabella Bank · CFO William Schaefer · Traded Feb 3
$6K
FUNC First United · Chairman Carissa Rodeheaver · Traded Feb 3
$5.19K
LCU Lion Copper & Gold · Director Charles Naugle · Traded Feb 4
$3.9K
RCG RENN Fund · President and CEO Murray Stahl · Traded Feb 4
$3.47K
NXL Nexalin Technology · Chief Medical Officer David Owens · Traded Feb 4
$3.1K
FUNC First United · SVP and COO Jason Rush · Traded Feb 3
$2.37K
FUNC First United · Director Brian Boal · Traded Feb 3
$2.12K
RKDA Arcadia Biosciences · CFO Mark Kawakami · Traded Feb 3
$1.74K
RKDA Arcadia Biosciences · CEO Thomas Schaefer · Traded Feb 3
$1.74K
ISBA Isabella Bank · Chief Credit Officer Jon Catlin · Traded Feb 3
$900
ISBA Isabella Bank · Chief Operations Officer Peggy Wheeler · Traded Feb 3
$750
ISBA Isabella Bank · President and CEO Jerome Schwind · Traded Feb 3
$600
RGCO RGC Resources · VP and Secretary Lawrence Oliver · Traded Feb 3
$200
RGCO RGC Resources · VP Christen Miles · Traded Feb 3
$100
Show 106 more real sales
CLS Celestica · President Todd Cooper · Traded Feb 3
$11.2M
CLS Celestica · Chief Operations Officer Yann Etienvre · Traded Feb 3
$10.2M
AJG Arthur J. Gallagher · Vice President Scott Hudson · Traded Feb 3
$7.06M
RBC RBC Bearings · Vice President and COO Daniel Bergeron · Traded Feb 4
$6.4M
USB US Bancorp · Chairman and CEO Andrew Cecere · Traded Feb 4
$4.82M
TSCO Tractor Supply · President and CEO Harry Lawton III · Traded Feb 3
$4.81M
USB US Bancorp · Vice Chair Terrance Dolan · Traded Feb 3
$3.11M
CW Curtiss Wright · Chair and CEO Lynn Bamford · Traded Feb 5
$2.88M
CLS Celestica · Chief Strategy Officer Alok Agrawal · Traded Feb 3–5
$2.7M
CLS Celestica · Chief Human Resources Officer Leila Wong · Traded Feb 3
$2.51M
CBSH Commerce Bancshares · President and CEO John Kemper · Traded Feb 4
$1.75M
LII Lennox International · Executive Vice President John Torres · Traded Feb 4
$1.04M
CW Curtiss Wright · Vice President and COO Kevin Rayment · Traded Feb 5
$924K
WT WisdomTree · Head of Europe Alexis Marinof · Traded Feb 4
$898K
BXP BXP · Executive Vice President Hilary Spann · Traded Feb 4
$892K
AJG Arthur J. Gallagher · Vice President Christopher Mead · Traded Feb 3
$878K
CW Curtiss Wright · Vice President and CFO K. Christopher Farkas · Traded Feb 5
$851K
AJG Arthur J. Gallagher · Director Sherry Barrat · Traded Feb 3
$761K
AMRX Amneal Pharmaceuticals · Director Gautam Patel · Traded Feb 3
$651K
RBC RBC Bearings · Director Dolores Ennico · Traded Feb 4
$514K
GO Grocery Outlet Holding · Director Eric Lindberg Jr. · Traded Feb 4
$499K
OTIS Otis Worldwide · EVP Nora LaFreniere · Traded Feb 5
$451K
ROP Roper Technologies · VP and Corporate Controller Brandon Cross · Traded Feb 4
$433K
LKFN Lakeland Financial · CEO David Findlay · Traded Feb 5
$432K
NFLX Netflix · Chief Legal Officer David Hyman · Traded Feb 4
$422K
CLS Celestica · Chief Legal Officer Douglas Parker · Traded Feb 3
$332K
CBSH Commerce Bancshares · Executive Vice President John Handy · Traded Feb 4
$326K
VZ Verizon Communications · EVP and Group CEO-VZ Business Kyle Malady · Traded Feb 3
$319K
TWST Twist Bioscience · CEO Emily Leproust · Traded Feb 3
$257K
XOM Exxon Mobil · VP - Corp Strategic Planning Darrin Talley · Traded Feb 4
$231K
CW Curtiss Wright · Vice President Strat and Bus Dev John Watts · Traded Feb 5
$216K
CW Curtiss Wright · VP and Corporate Controller Gary Ogilby · Traded Feb 5
$191K
VIAV Viavi Solutions · Director Keith Barnes · Traded Feb 4
$189K
JETMF Global Crossing Airlines Group · Director Deborah Robinson · Traded Aug 6–12
$185K
HWBK Hawthorn Bancshares · Director Jonathan Holtaway · Traded Feb 3–4
$180K
DIOD Diodes · President Gary Yu · Traded Feb 4
$163K
TRAK ReposiTrak · CEO Randall Fields · Traded Feb 3–4
$157K
PKBK Parke Bancorp · Director Jeffrey Kripitz · Traded Feb 3–4
$153K
USB US Bancorp · EVP and Controller Lisa Stark · Traded Feb 3
$151K
RBC RBC Bearings · Director Michael Ambrose · Traded Feb 5
$145K
TWST Twist Bioscience · President and COO Patrick Finn · Traded Feb 3
$140K
CW Curtiss Wright · Vice President and Treasurer Robert Freda · Traded Feb 5
$131K
SYM Symbotic · CFO Carol Hibbard · Traded Feb 5
$124K
BR Broadridge Financial Solutions · CVP Laura Matlin · Traded Feb 4
$124K
SPRO Spero Therapeutics · CEO and President Sath Shukla · Traded Feb 5
$121K
CBSH Commerce Bancshares · Senior Vice President Patricia Kellerhals · Traded Feb 4
$116K
TXN Texas Instruments · Director Mark Blinn · Traded Feb 4
$107K
NTRS Northern Trust · Controller John Landers · Traded Feb 4
$100K
RLEA Rubber Leaf · CFO and Secretary Hua Wang · Traded Jan 27
$100K
TOST Toast · CFO Elena Gomez · Traded Feb 4
$81.3K
ALLO Allogene Therapeutics · President and CEO David Chang · Traded Feb 3
$77.3K
FOX Fox · Chief Legal and Policy Officer Adam Ciongoli · Traded Feb 5
$69.2K
TWST Twist Bioscience · SVP of Human Resources Paula Green · Traded Feb 3
$62.1K
VIAV Viavi Solutions · EVP Paul McNab · Traded Feb 4
$60.1K
SPRO Spero Therapeutics · Director Ankit Mahadevia · Traded Feb 5
$54K
DIOD Diodes · SVP Worldwide Sales/Marketing Emily Yang · Traded Feb 4
$53.2K
UNTY Unity Bancorp · Chief Lending Officer/FSVP James Donovan · Traded Feb 4
$52.8K
DIOD Diodes · CFO Brett Whitmire · Traded Feb 4
$46.5K
NE Noble · SVP Joey Kawaja · Traded Feb 3
$45.2K
SPRO Spero Therapeutics · COO Timothy Keutzer · Traded Feb 5
$44.1K
TOST Toast · CEO Aman Narang · Traded Feb 4
$42.3K
TOST Toast · President Stephen Fredette · Traded Feb 4
$42.3K
AMLX Amylyx Pharmaceuticals · Co-CEO Justin Klee · Traded Feb 3
$41.1K
AMLX Amylyx Pharmaceuticals · Co-CEO Joshua Cohen · Traded Feb 3
$41.1K
TOST Toast · Chief Revenue Officer Jonathan Vassil · Traded Feb 4
$39.9K
TWST Twist Bioscience · Officer Dennis Cho · Traded Feb 3
$39.8K
ALLO Allogene Therapeutics · EVP of R&D Zachary Roberts · Traded Feb 3
$32K
RENT Rent the Runway · Chair Jennifer Hyman · Traded Feb 3–4
$29.1K
QMCO Quantum · CFO Kenneth Gianella · Traded Feb 3
$27.5K
TOST Toast · General Counsel Brian Elworthy · Traded Feb 4
$25.9K
ALLO Allogene Therapeutics · Chief Technical Officer Timothy Moore · Traded Feb 3
$25.2K
ZNTL Zentalis Pharmaceuticals · Chief Scientific Officer Mark Lackner · Traded Feb 3
$24.6K
ZNTL Zentalis Pharmaceuticals · Chief Legal Officer Andrea Paul · Traded Feb 3
$22.6K
RMNI Rimini Street · EVP and CFO Michael Perica · Traded Feb 3
$21.9K
SEER Seer · CEO and Chair Omid Farokhzad · Traded Feb 4
$18.1K
OFIX Orthofix Medical · CAO Geoffrey Gillespie · Traded Feb 3–4
$17K
SPRO Spero Therapeutics · CFO and CBO Esther Rajavelu · Traded Feb 5
$16.1K
RMNI Rimini Street · EVP Kevin Maddock · Traded Feb 3
$15.7K
CBSH Commerce Bancshares · Senior Vice President Derrick Brooks · Traded Feb 3–4
$13.5K
RMNI Rimini Street · EVP and Chief Client Officer Nancy Lyskawa · Traded Feb 3
$13.1K
AMLX Amylyx Pharmaceuticals · Chief Legal Officer Gina Mazzariello · Traded Feb 3
$12.8K
ALLO Allogene Therapeutics · SVP Earl Douglas · Traded Feb 3
$11K
RMNI Rimini Street · CPO David Rowe · Traded Feb 3
$9.8K
BPRN Princeton Bancorp · Chief Information Officer Matthew Clark · Traded Nov 6
$9.36K
TWST Twist Bioscience · Chief Accounting Officer Robert Werner · Traded Feb 3
$9.13K
ACCD Accolade · CEO Rajeev Singh · Traded Feb 4
$8.11K
SEER Seer · President and CFO David Horn · Traded Feb 4
$7.95K
ALLO Allogene Therapeutics · CFO Geoffrey Parker · Traded Feb 3
$7.54K
SIBN Si-Bone · Director Jeffrey Dunn · Traded Feb 3
$5.56K
VSTM Verastem · President and CEO Dan Paterson · Traded Feb 4
$4.89K
ZNTL Zentalis Pharmaceuticals · PAO and Interim PFO Vincent Vultaggio · Traded Feb 3
$4.47K
PUBM PubMatic · Chief Accounting Officer Lisa Gimbel · Traded Feb 3
$4.41K
ACCD Accolade · President Robert Cavanaugh · Traded Feb 4
$3.86K
AMWL American Well · President Phyllis Gotlib · Traded Feb 3
$3.14K
ACCD Accolade · CFO Stephen Barnes · Traded Feb 4
$3.1K
PCF High Income Securities Fund · Director P Das Rajeev · Traded Feb 4
$2.89K
CBUS Cibus · Director Gerhard Prante · Traded Feb 4
$2.82K
ACCD Accolade · EVP General Counsel Richard Eskew · Traded Feb 4
$2.7K
KPTI Karyopharm Therapeutics · President and CEO Richard Paulson · Traded Feb 4
$2.66K
UBX Unity Biotechnology · CEO Anirvan Ghosh · Traded Feb 4
$1.43K
IPSC Century Therapeutics · Chief Operations Officer Adrienne Farid · Traded Feb 3
$822
UBX Unity Biotechnology · CLO and Head of Ops Alexander Nguyen · Traded Feb 4
$366
UBX Unity Biotechnology · CFO and Head of Corp. Dev. Lynne Sullivan · Traded Feb 4
$341
IPSC Century Therapeutics · SVP Finance and Operations Douglas Carr · Traded Feb 3
$274
SDIG Stronghold Digital Mining · Senior Vice President Richard Shaffer · Traded Jan 30
$129
AMWL American Well · Chief Accounting Officer Paul McNeice · Traded Feb 3
$95

13F season

Holdings as of Dec 31, 2024 are due Feb 14

81 funds have filed so far. 58 filed for the quarter before.

Biggest real insider buys, Jan 30–Feb 5

Open-market buys by officers and directors, filed in the 7 days up to Feb 5.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist